Affiliation:
1. Departments of Internal Medicine
2. Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei County, Taiwan
3. Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei
Abstract
ABSTRACT
This study reports data on the susceptibilities to five commonly used antianaerobic agents of five clinically frequently encountered anaerobes from 2000 to 2007 and to
Bacteroides fragilis
isolates causing nosocomial infections from 1990 to 2006. There was a trend of decreasing susceptibilities of these anaerobes to ampicillin-sulbactam, cefmetazole, chloramphenicol, and clindamycin with time during the study period. The rates of susceptibility to clindamycin and cefmetazole for all clinical isolates of
Bacteroides fragilis
isolates were higher than those of isolates associated with nosocomial infections. The MICs of 207 anaerobic blood isolates collected in 2006 to 14 antimicrobial agents were determined by the agar dilution method. The rates of nonsusceptibility to imipenem and meropenem were 7% and 12% for
B. fragilis
isolates (
n
= 60), 7% and 3% for
Bacteroides thetaiotamicron
isolates (
n
= 30), 4% and 4% for
Fusobacterium
species (
n
= 27), 6% and 0% for
Prevotella
species (
n
= 16), 15% and 0% for
Clostridium
species (
n
= 28), and 0% and 0% for
Peptostreptococcus
species (
n
= 32). The rates of susceptibility to moxifloxacin were 90% for
B. fragilis
isolates, 87% for
B. thetaiotaomicron
isolates, 81% for
Fusobacterium
species, 75% for
Prevotella
species, 93% for
Clostridium
species, and 78% for
Peptostreptococcus
species. Thirty-six percent of
Clostridium
species and 12% of
Peptostreptococcus
species were not susceptible to metronidazole. Comparison of the data with the data from a previous survey from the same institute in 2002 revealed higher rates of nonsusceptibility to carbapenems, especially for
B. fragilis
,
Fusobacterium
species, and
Prevotella
species isolates. The high rates of nonsusceptibility to commonly used antianaerobic agents mandate our attention, and periodic monitoring of the trend of the resistance is crucial.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology